ABSTRACT Pulmonary function was measured in 169 male patients seropositive for the human immunodeficiency virus (HIV). The transfer factor for carbon monoxide (TLCO) in symptom free patients and patients with persistent generalised lymphadenopathy was normal (> 83% of predicted values). Patients with the AIDS related complex, non-pulmonary Kaposi sarcoma, and nonpulmonary non-Kaposi sarcoma AIDS (that is, opportunist infections affecting other organs) had lower mean values for TLCO (77%, 70%, and 70% of predicted respectively). These values were significantly lower than values for symptom free patients. Lower mean values of 50% and 63% predicted TLCO were observed in patients during the acute and recovery phases of Pneumocystis carinii pneumonia. TLCO was also low in patients with lung mycobacterial infection and in a patient with lung Kaposi sarcoma. Forced expiratory volume in one second, peak expiratory flow, and maximal expiratory flow at 50% of vital capacity were significantly reduced only in patients with acute pneumocystis pnemonia. This study shows that abnormalities in the results of pulmonary function tests, particularly TLCO, although greatest in patients with pulmonary complications of AIDS, are also present in patients with AIDS but without other evidence ofpulmonary disease, and in patients with the AIDS related complex. The predictive and prognostic implications of these findings require further investigation.
Disease produced by the human immunodeficiency virus (HIV) is rapidly becoming a major health care problem. Pulmonary complications occur in over 40% of patients.'2 Of these, Pneumocystis carinii pneumonia is the most common (84%), and may pose diagnostic difficulties because the symptoms ofbreathlessness and cough often have an insidious onset and may have other causes. Physical examination is rarely helpful and the chest radiograph may be normal. Low values for carbon monoxide transfer factor (TLCO) and vital capacity (VC) have been shown to occur in acute Pneumocystis carinii infection.' In this study we report abnormalities of pulmonary function in other categories of HIV related disease and compare them with those found in patients with AIDS and pneumocystis pneumonia. TLCO was low in patients with AIDS who had Kaposi sarcoma (mainly cutaneous) but no pulmonary disease (p < 0-01). In patients with AIDS with neither Kaposi sarcoma nor pulmonary disease (that is, with opportunist infections affecting other organs) both TLCO and Kco were lower than in the symptom free HIV positive group (p < 0-01 and < 0 05).
PATIENTS WITH AIDS AND PULMONARY

COMPLICATIONS
Patients with AIDS and pulmonary complications had greater reductions in lung function. Mean TLCO, KCo, and FVC were lower in acute pneumocystis pneumonia than in the HIV positive group (p < 0 001, < 0-01, < 0 001) or in the patients with non-pulmonary Kaposi sarcoma (p < 0-001, < 0 05, < 0-001), and TLCO and FVC were lower than in AIDS patients without Kaposi sarcoma or opportunist lung infection "early" pneumocystis pneumonia and abnormalities of lung function were the first manifestation. Similarly, the abnormalities seen in patients with the AIDS related complex may be the first indication of the slow development of their first opportunist pulmonary infection or neoplasm. Alternatively, infection with HIV may result in lung damage directly. Direct damage occurs in other organs (for example, in AIDS encephalopathy'3), and HIV has been isolated from lung tissue and alveolar macrophages from patients with AIDS.'4 The changes in pulmonary function may therefore be the result of a non-specific interstitial pneumonitis, which is being increasingly recognised in the context of HIV related disease.'516 Prospective longitudinal studies may clarify this issue. We did not routinely measure arterial blood gas tensions or the alveolar-arterial oxygen difference in these patients (although arterial blood gas tensions were measured before bronchoscopy).
This study showed that routine lung function tests, particularly the TLCO, were a useful adjunct in identifying patients with pulmonary complications of AIDS, the values being lower than in the other patients who had reductions. In view of the overlap with other groups of patients, however, abnormalities of lung function need to be interpreted and acted on in the context of the clinical presentation and the chest radiograph. Isolated measurements are probably of less value than sequential measurements. A reduction in TLCO is, however, a sensitive if not specific index of pulmonary complications in AIDS, and if found in an individual patient should encourage further investigation, such as bronchoscopy. This study also showed that abnormalities in results of lung function tests occurred without overt clinical evidence of pulmonary disease in patients with HIV infection. A satisfactory explanation for the observed reductions in lung function in those with the AIDS related complex and nonpulmonary AIDS remains to be found, and the prognostic and predictive value of these changes needs to be evaluated. 
